Open AccessAnti‐TNF‐alpha drugs ‐ moving into the mainstream?
Author(s) -
Ding Tina,
Deighton Chris
Publication year - 2009
Publication title -
future prescriber
Language(s) - English
Resource type - Journals
eISSN - 1931-2261
pISSN - 1468-9871
DOI - 10.1002/fps.55
Subject(s) - medicine , rheumatoid arthritis , tumor necrosis factor alpha , mainstream , antirheumatic drugs , pharmacology , antirheumatic agents , intensive care medicine , political science , law
Anti‐TNF drugs are a major treatment advance in the management of inflammatory disorders such as rheumatoid arthritis, and are typically considered following unsuccessful treatment with conventional disease‐modifying antirheumatic drugs (DMARDs). Drs Chris Deighton and Tina Ding review the available anti‐TNF‐alpha drugs, and consider their future place in therapy. Copyright © 2009 John Wiley & Sons, Ltd.